Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rosenkranz

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Pharmacology|January 1, 1985
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamideU Klotz, P Arvela, B Rosenkranz
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 17, 2014
Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challengesCharles Awortwe, P S Fasinu, B Rosenkranz
Clinical Pharmacology and Therapeutics|March 1, 1981
Prostacyclin metabolites in human plasmaB Rosenkranz, C Fischer, J C Frölich
Clinical Pharmacokinetics|March 1, 1995
Clinical pharmacokinetics of dipyrone and its metabolitesM Levy, E Zylber-Katz, B Rosenkranz
Deutsche Medizinische Wochenschrift (1946)|March 29, 1985
[Pseudothrombocytopenia--an error in the determination of thrombocyte count]B Rosenkranz, H Wisser, J C Bode
Journal of Cardiovascular Pharmacology|September 1, 1986
Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteersB Rosenkranz, H Ledermann, J C Frölich
British Journal of Clinical Pharmacology|November 1, 1986
Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?U Klotz, G Ziegler, B Rosenkranz, et al.
Clinical Pharmacokinetics|May 1, 1996
Clinical pharmacokinetics of molsidomineB Rosenkranz, B R Winkelmann, M J Parnham
Current Medical Research and Opinion|January 1, 1987
Absence of interaction between ofloxacin and phenprocoumonM Verho, V Malerczyk, B Rosenkranz, et al.
Drugs|January 1, 1988
A pharmacokinetic study of roxatidine acetate in chronic renal failureN Lameire, B Rosenkranz, L Maass, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Pharmacology|January 1, 1985
Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamideU Klotz, P Arvela, B Rosenkranz
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 17, 2014
Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challengesCharles Awortwe, P S Fasinu, B Rosenkranz
Clinical Pharmacology and Therapeutics|March 1, 1981
Prostacyclin metabolites in human plasmaB Rosenkranz, C Fischer, J C Frölich
Clinical Pharmacokinetics|March 1, 1995
Clinical pharmacokinetics of dipyrone and its metabolitesM Levy, E Zylber-Katz, B Rosenkranz
Deutsche Medizinische Wochenschrift (1946)|March 29, 1985
[Pseudothrombocytopenia--an error in the determination of thrombocyte count]B Rosenkranz, H Wisser, J C Bode
Journal of Cardiovascular Pharmacology|September 1, 1986
Interaction between nifedipine and atenolol: pharmacokinetics and pharmacodynamics in normotensive volunteersB Rosenkranz, H Ledermann, J C Frölich
British Journal of Clinical Pharmacology|November 1, 1986
Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?U Klotz, G Ziegler, B Rosenkranz, et al.
Clinical Pharmacokinetics|May 1, 1996
Clinical pharmacokinetics of molsidomineB Rosenkranz, B R Winkelmann, M J Parnham
Current Medical Research and Opinion|January 1, 1987
Absence of interaction between ofloxacin and phenprocoumonM Verho, V Malerczyk, B Rosenkranz, et al.
Drugs|January 1, 1988
A pharmacokinetic study of roxatidine acetate in chronic renal failureN Lameire, B Rosenkranz, L Maass, et al.
Pageof 5